265 related articles for article (PubMed ID: 31737072)
21. MicroRNA based theranostics for brain cancer: basic principles.
Petrescu GED; Sabo AA; Torsin LI; Calin GA; Dragomir MP
J Exp Clin Cancer Res; 2019 May; 38(1):231. PubMed ID: 31142339
[TBL] [Abstract][Full Text] [Related]
22. miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer.
Chakrabortty A; Patton DJ; Smith BF; Agarwal P
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510280
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA and Cardiovascular Diseases.
Çakmak HA; Demir M
Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
[TBL] [Abstract][Full Text] [Related]
24. A review of the current understanding and clinical utility of miRNAs in esophageal cancer.
Sakai NS; Samia-Aly E; Barbera M; Fitzgerald RC
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):512-21. PubMed ID: 24013023
[TBL] [Abstract][Full Text] [Related]
25. The Role of miRNA and Related Pathways in Pathophysiology of Uterine Fibroids-From Bench to Bedside.
Ciebiera M; Włodarczyk M; Zgliczyński S; Łoziński T; Walczak K; Czekierdowski A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344726
[TBL] [Abstract][Full Text] [Related]
26. Emerging roles of microRNAs in acute lymphoblastic leukemia and their clinical prospects.
Deng W; Pan M; Zhu S; Chao R; Wang L
Expert Rev Hematol; 2021 Nov; 14(11):987-992. PubMed ID: 34784832
[TBL] [Abstract][Full Text] [Related]
27. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
Essig S; Li Q; Chen Y; Hitzler J; Leisenring W; Greenberg M; Sklar C; Hudson MM; Armstrong GT; Krull KR; Neglia JP; Oeffinger KC; Robison LL; Kuehni CE; Yasui Y; Nathan PC
Lancet Oncol; 2014 Jul; 15(8):841-51. PubMed ID: 24954778
[TBL] [Abstract][Full Text] [Related]
28. Novel MicroRNA Biomarkers for Colorectal Cancer Early Diagnosis and 5-Fluorouracil Chemotherapy Resistance but Not Prognosis: A Study from Databases to AI-Assisted Verifications.
Zhang X; Zhang H; Shen B; Sun XF
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32028703
[TBL] [Abstract][Full Text] [Related]
29. The diagnosis, prognosis, and therapeutic application of MicroRNAs in haematological malignancies.
Li X; Zhong H
Hematology; 2016 Jun; 21(5):263-71. PubMed ID: 26907667
[TBL] [Abstract][Full Text] [Related]
30. Challenges and opportunities of microRNAs in lymphomas.
De Tullio G; De Fazio V; Sgherza N; Minoia C; Serratì S; Merchionne F; Loseto G; Iacobazzi A; Rana A; Petrillo P; Silvestris N; Iacopino P; Guarini A
Molecules; 2014 Sep; 19(9):14723-81. PubMed ID: 25232701
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatment.
Fazi F; Blandino G
Microrna; 2013; 2(2):81. PubMed ID: 25070777
[TBL] [Abstract][Full Text] [Related]
33. Non-coding RNAs as potential biomarkers of gallbladder cancer.
Lv Y; Yin W; Zhang Z
Clin Transl Oncol; 2023 Jun; 25(6):1489-1511. PubMed ID: 36576705
[TBL] [Abstract][Full Text] [Related]
34. Progress in microRNA delivery.
Zhang Y; Wang Z; Gemeinhart RA
J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
[TBL] [Abstract][Full Text] [Related]
35. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
Shin VY; Chu KM
World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
[TBL] [Abstract][Full Text] [Related]
37. Aberrant microRNA expression and its implications in the pathogenesis of leukemias.
Babashah S; Sadeghizadeh M; Tavirani MR; Farivar S; Soleimani M
Cell Oncol (Dordr); 2012 Oct; 35(5):317-34. PubMed ID: 22956261
[TBL] [Abstract][Full Text] [Related]
38. The clinical utility of dysregulated microRNA expression in paediatric solid tumours.
Chadda KR; Blakey EE; Coleman N; Murray MJ
Eur J Cancer; 2022 Nov; 176():133-154. PubMed ID: 36215946
[TBL] [Abstract][Full Text] [Related]
39. The Oncogenic and Tumor Suppressive Long Non-Coding RNA-microRNA-Messenger RNA Regulatory Axes Identified by Analyzing Multiple Platform Omics Data from Cr(VI)-Transformed Cells and Their Implications in Lung Cancer.
Sweef O; Yang C; Wang Z
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289596
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
